QTRX(Quanterix Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $110.56M | $105.52M | $122.37M | $137.42M | $138.90M |
| 毛利润 | $64.77M | $45.36M | $74.22M | $83.10M | $64.96M |
| 营业利润 | −$56.52M | −$104.26M | −$45.99M | −$52.62M | −$125.54M |
| 净利润 | −$55.55M | −$99.57M | −$28.35M | −$38.53M | −$107.15M |
| 经营现金流 | −$47.62M | −$48.61M | −$18.85M | −$35.16M | −$77.24M |
| 自由现金流 | −$61.30M | −$60.23M | −$22.69M | −$38.53M | −$79.85M |
| 摊薄每股收益 | $-1.54 | $-2.69 | $-0.75 | $-1.00 | $-2.51 |